Thus far that doesn't seem to be the case but who knows what will happen in the future.
I'm not seeing this in the link you posted ( https://www.medrxiv.org/content/10.1101/2020.02.18.20024539v... )
A quick online search isn't yielding anything substantial on that either.
EDIT: N/M found it, but they're saying it's a possibility due to observations found during SARS:
> Gaohong Sheng et al. [20] have shown that viral infection can increase the risk of pulmonary fibrosis.Xie et al. [21] found that 45% of patients showed signs of pulmonary fibrosis within one month after being infected with SARS-CoV.Hui et al. [22] found that 36% and 30% of patients infected with SARS-CoV developed pulmonary fibrosis at 3 and 6 months after infection, respectively.Therefore, we believe that pulmonary fibrosis will become one of the serious complications in patients with 2019-nCoV infection.How to prevent and reduce the occurrence of pulmonary fibrosis in patients with 2019-nCoV infection is an urgent problem for medical workers in the treatment of 2019-nCoV.